Health Secretary Robert F. Kennedy Jr. endorsed the expanded use of RSV vaccines for people 50 through 59 years old who are ...

Following its acquisition by Supernus Pharmaceuticals, Sage Therapeutics has let go of all of its remaining workforce, which ...

A new study from the University of Oxford has revealed a surprising benefit of the respiratory syncytial virus (RSV) vaccine: ...

The new RSV recommendation calls for a single dose of vaccine for adults age 50 to 59 years who are at increased risk of ...

The expanded recommendation is good news for Moderna, Pfizer, and GSK, which all sell RSV vaccines for older adults. Moderna ...

The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60 ...

Session ID: 2025-07-03:9a61974b939236f32b419e45 Player Element ID: V3f69f3ef_05ce_43e7_acbe_c951afabbbb5_6374131301112 ...

HealthDay News — A newly approved shot could soon help protect babies from respiratory syncytial virus (RSV), the top cause of hospitalization in U.S. infants. The U.S. Food and Drug Administration ...

June 17, 2025 – The FDA has expanded the use of Moderna's respiratory syncytial virus (RSV) shot to all adults, with some limits on who can get it. First approved in 2024 for people 60 or older ...

HealthDay News — A newly approved shot could soon help protect babies from respiratory syncytial virus (RSV), the top cause of hospitalization in U.S. infants. The U.S. Food and Drug ...

FDA approves expanded use of Moderna’s RSV shot, but uncertainty remains by: Nathaniel Weixel, The Hill Posted: Jun 15, 2025 / 09:03 AM CDT Updated: Jun 15, 2025 / 09:03 AM CDT ...

FDA approves expanded use of Moderna’s RSV shot, but uncertainty remains by: Nathaniel Weixel, The Hill Posted: Jun 14, 2025 / 06:24 PM CDT Updated: Jun 14, 2025 / 06:24 PM CDT ...